PKR , a p53 target gene, plays a crucial role in the tumor-suppressor function of p53
- 12 May 2009
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (19) , 7852-7857
- https://doi.org/10.1073/pnas.0812148106
Abstract
Type I IFN-induced expression of dsRNA-activated protein kinase (PKR) during viral infection is a well-established antiviral mechanism. However, little is known about the expression of PKR in the context of p53 and about PKR involvement in p53-mediated tumor suppression. Here, we report that PKR is a p53 target gene and plays an important role in the tumor-suppressor function of p53. Activation of p53 by genotoxic stress induces a significant level of PKR expression by acting on the newly identified cis-acting element (ISRE), which is separated from the IFN-stimulated responsive element on the PKR promoter, resulting in translational inhibition and cell apoptosis. The genotoxin-mediated inhibition of translation is associated with the p53/PKR/elF2a (eukaryotic initiation factor-2alpha) pathway. To some extent, p53 activation induced by DNA damage facilitates cell apoptosis by activating PKR. PKR-knockdown human colon cancer cells grew rapidly in nude mice and proved resistant to anti-cancer drugs. These data indicate that p53-mediated tumor suppression can be attributed at least in part to the biological functions of PKR induced by p53 in genotoxic conditions.Keywords
This publication has 35 references indexed in Scilit:
- Transcriptional role of p53 in interferon-mediated antiviral immunityThe Journal of Experimental Medicine, 2008
- Principles of Tumor SuppressionCell, 2004
- p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and NoxaScience, 2003
- Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defenceNature, 2003
- Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53Genes & Development, 1998
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- Isolation of the Interferon-Inducible RNA-Dependent Protein KinasePkrPromoter and Identification of a Novel DNA Element within the 5′-Flanking Region of Human and MousePkrGenesVirology, 1997
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Definition of a consensus binding site for p53Nature Genetics, 1992
- INTERFERONS IN CANCER THERAPY: A REAPPRAISALThe Lancet, 1987